Table 1.
CN-AML patient's characteristics.
Item | No (%) |
---|---|
Sex | |
Male | 45 |
Female | 35 |
FAB subtypes | |
M0 | 3 (3.7%) |
M1 | 15(18.7%) |
M2 | 17(21.3%) |
M4 | 35(43.8%) |
M5 | 10(12.5%) |
Induction of remission | |
Responder | 45 |
Non-responder | 35 |
CN AML Positive CD25+/CD123+ co-expression |
17 |
CN-AML Lack CD25+/CD123+ Co-expression |
63 |
Deaths | |
Alive | 47 |
Dead | 33 |